$ AAPL

$ ABBV

$ ABNB

$ ACGL

$ ADI

$ ADM

$ ADP

$ ADSK

$ AEE

$ AEP

$ AES

$ AFL

$ AIG

$ AIZ

$ AJG

$ AKAM

$ ALB

$ ALGN

$ ALL

$ AMAT

$ AMCR

$ AMD

$ AME

$ AMGN

$ AMP

$ AMT

$ AMZN

$ ANET

$ AOS

$ APA

$ APD

$ APO

$ APTV

$ ARE

$ ATO

$ AVB

$ AWK

$ AXON

$ BA

$ BALL

$ BAX

$ BBY

$ BDX

$ BEN

$ BG

$ BIIB

$ BKNG

$ BLDR

$ BMY

$ BR

$ BRO

$ BXP

$ CAG

$ CAH

$ CARR

$ CAT

$ CBOE

$ CBRE

$ CCL

$ CDNS

$ CDW

$ CEG

$ CF

$ CHD

$ CHRW

$ CI

$ CINF

$ CL

$ CLX

$ CMCSA

$ CMG

$ CMI

$ CMS

$ COIN

$ COO

$ COP

$ COR

$ CPAY

$ CPT

$ CRL

$ CRWD

$ CSCO

$ CTRA

$ CTSH

$ CTVA

$ CVS

$ CVX

$ CZR

$ DAL

$ DASH

$ DAY

$ DD

$ DDOG

$ DE

$ DELL

$ DG

$ DGX

$ DIS

$ DOC

Xylem posts record Q2 2025 margins and raises guidance, but regional headwinds and efficiency gaps pose ongoing risks for investors.

# Xylem Delivers Strong Q2 2025 Beat with Record Margins, But Regional and Efficiency Risks Linger

---

## Executive Summary

- **Xylem (XYL) delivered a robust Q2 2025, beating consensus on both revenue and EPS.** Revenue reached **$2.3 billion** (up 6% YoY, 5% organic), and Adjusted EPS climbed **16% YoY to $1.26**, both above expectations.  
- **Earnings quality was high,** with record **Adjusted EBITDA margin of 21.8%** (up 100 bps YoY) and operating margin at **13.3%** (up 160 bps YoY), reflecting effective cost and productivity initiatives. However, **net margin (9.8%) and return metrics (ROE 1.58%, ROA 1.02%) remain below industry benchmarks**, highlighting ongoing efficiency challenges.
- **Management struck a bullish tone,** raising full-year revenue and EPS guidance and emphasizing a strong M&A pipeline and robust backlog (over $5B). The outlook is optimistic, but assumes continued organic growth and successful integration of acquisitions.
- **Risks remain underappreciated,** particularly the **18% YoY decline in China orders, tariff uncertainties, and persistent operating efficiency gaps.** These may not be fully reflected in current market valuations.
- **Catalyst watch:** Near-term, expect positive market reaction to the beat and raised guidance. Key upcoming catalysts include further M&A announcements and updates on China/regional performance.

---

## Performance Snapshot

| Metric                | Reported   | Consensus | Surprise | YoY Change |
|-----------------------|------------|-----------|----------|------------|
| Revenue               | $2.3B      | $2.22B    | +$80M    | +6%        |
| Adjusted EPS          | $1.26      | $1.18     | +$0.08   | +16%       |
| Adjusted EBITDA Margin| 21.8%      | 20.8%     | +100 bps | +100 bps   |
| Operating Margin      | 13.3%      | 11.7%     | +160 bps | +160 bps   |
| Net Margin            | 9.8%       | 10.5%*    | -70 bps  | +40 bps    |
| Orders (China)        | -18% YoY   |           |          |            |
| Backlog               | $5B+       |           |          |            |

*Industry benchmark

---

## Earnings Quality

Xylem’s Q2 2025 results reflect **high-quality earnings** driven by broad-based organic growth and disciplined cost management. The company achieved **record margins** despite ongoing inflationary and tariff pressures, with cost controls and productivity initiatives offsetting potential margin dilution (estimated 10–25 bps impact in H2). However, the **net margin and return metrics (ROE/ROA) remain below peers**, indicating that while operational execution is strong, underlying efficiency improvements are still needed.

---

## Management Commentary & Guidance

Management’s tone was **decisively bullish**, highlighting strong organic growth, margin expansion, and successful cost initiatives. The company **raised full-year revenue and EPS guidance** and pointed to a robust M&A pipeline and backlog as key drivers for continued outperformance. The updated outlook is **realistic but slightly aggressive**, banking on sustained organic momentum and successful M&A execution.

---

## Key Risks

- **Regional headwinds:** Notably, an **18% YoY decline in China orders** and ongoing tariff uncertainties could pressure future growth.
- **Operating efficiency:** **Low ROE (1.58%) and ROA (1.02%)** signal that Xylem’s capital efficiency lags industry standards.
- **Margin sustainability:** While current margins are strong, persistent cost inflation and potential tariff volatility could erode gains.

---

## Expected Market Reaction

Analysts and investors are likely to **react positively** to the clear beats on revenue, EPS, and margins, as well as the raised guidance and bullish management tone. However, **concerns over regional exposure and operating efficiency** may temper enthusiasm, especially among more risk-averse investors.

---

## Final Takeaway

**Xylem’s Q2 2025 was a strong quarter, marked by record margins and robust organic growth.** The market may be underestimating the risks from regional headwinds and efficiency gaps, even as it prices in much of the upside from margin improvements and backlog strength. **Key upcoming catalysts** include further M&A activity and updates on China/regional performance. Investors should watch for sustained margin performance and progress on capital efficiency to confirm the durability of Xylem’s current momentum.

Xylem (XYL): Record Margins, Regional Risks Persist

Xylem’s Q2 FY2025 outlook is supported by margin expansion and a strong backlog, but working capital outflows and macro headwinds limit near-term upside.

# Xylem Inc. ($XYL): Navigating Margin Expansion and Backlog Strength Amid Macro Uncertainty – Q2 FY2025 Earnings Outlook

## Executive Summary

We maintain a **Neutral** outlook on Xylem Inc. ($XYL) for the upcoming Q2 FY2025 earnings, expecting **modest revenue growth of 1%–2% (2%–3% organic)** and **EPS in the $1.12–$1.16 range**. Margin expansion in core segments and a robust backlog (~$5.1 billion) provide near-term revenue visibility and support for profitability. However, **persistent working capital outflows** (Q1 FCF: -$38 million) and ongoing tariff/FX headwinds temper upside potential. The market may be underestimating the impact of recent **cost structure simplification initiatives**, which could drive incremental margin improvement if execution is strong in Q2.

## Recent Trends Signal What’s Next

Xylem’s last two quarters have demonstrated **stable top-line growth and improving margins**. Q1 FY2025 revenue was **$2.07 billion** (up modestly YoY), with **gross margin at 37.1%** and **operating margin at 11.2%**—both up sequentially. Segment-level performance was led by Water Infrastructure (operating margin +330 bps YoY) and Applied Water (+260 bps YoY). The company’s **book-to-bill ratio remained above 1**, and backlog reached **$5.1 billion**, supporting near-term revenue conversion.

### Quarterly Financial Trend Table

| Quarter      | Revenue ($B) | Gross Margin (%) | Operating Margin (%) | EPS ($) |
|--------------|--------------|------------------|----------------------|---------|
| Q3 FY2024    | 2.04         | 36.2             | 10.5                 | 1.08    |
| Q4 FY2024    | 2.09         | 36.7             | 10.9                 | 1.11    |
| Q1 FY2025    | 2.07         | 37.1             | 11.2                 | 1.13    |
| Q2 FY2025E   | 2.09–2.11    | 37.0–37.2         | 11.2–11.4            | 1.12–1.16|

**Trend:** Revenue and margins have shown steady improvement, with EPS tracking higher each quarter.

## Management’s Forward Tone and Positioning

Management’s Q1 FY2025 commentary was **cautiously optimistic**, emphasizing operational resilience but acknowledging external risks. CEO Patrick Decker stated, _“We’re seeing early signs of normalization in demand, but remain nimble in the face of dynamic tariffs and FX volatility.”_ This is a **more balanced tone** compared to the prior quarter’s focus on “robust demand and backlog strength.” The Q2 guidance reaffirmation (revenue +1%–2%, EPS $1.12–$1.16) signals confidence in execution, but the language around “uncertainty” and “cost discipline” suggests a more vigilant approach to macro headwinds.

## KPI Trends & Upcoming Quarter Drivers

The most relevant KPIs for Q2 are **book-to-bill ratio, backlog conversion, and working capital efficiency**:

### KPI Movement Table

| KPI                  | Q1 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025E | YoY Change | QoQ Change |
|----------------------|-----------|-----------|-----------|------------|------------|------------|
| Book-to-Bill Ratio   | 1.05      | 1.03      | 1.02      | 1.01–1.03  | -0.04      | -0.01      |
| Backlog ($B)         | 4.8       | 5.0       | 5.1       | 5.0–5.2    | +0.3       | +0.1       |
| FCF ($M)             | 42        | 61        | -38       | 0–20       | -80        | +38        |

- **Book-to-bill above 1** and a **backlog of $5.1B** support revenue stability.
- **Working capital outflows** (Q1 FCF: -$38M) are a risk to near-term cash flow, but capex remains stable (~$71M/quarter).
- **Backlog conversion**: Management expects ~50% of backlog to convert in FY2025, supporting Q2 revenue.

## Missed by the Street

A key overlooked signal is the **increase in restructuring charges in Q1**, indicating active cost structure adjustments. Management’s reference to “simplification” and “process improvements” in the transcript suggests a **potential margin tailwind** not fully reflected in consensus. For example, the CFO noted, _“We expect to see the benefits of our cost actions begin to flow through in the second half.”_ If these initiatives deliver, Q2 margins could surprise to the upside.

## Scenarios for the Upcoming Quarter

### Scenario Table

| Scenario | Revenue ($B) | EPS ($) | EBITDA Margin (%) | Key Assumptions                                      |
|----------|--------------|---------|-------------------|------------------------------------------------------|
| Bull     | 2.11         | 1.18    | 21.5              | Strong backlog conversion, lower FX/tariff impact    |
| Base     | 2.09         | 1.14    | 21.2              | Steady orders, modest input cost easing              |
| Bear     | 2.07         | 1.12    | 21.0              | Tariff/FX headwinds persist, working capital outflow |

**Most Likely:** The **Base case** is most probable, given stable order trends, backlog conversion, and management’s cautious tone. Upside exists if cost actions deliver faster-than-expected margin improvement.

## Appendix – Data Tables & Management Quotes

### Quarterly Revenue, EPS, and Margin Trends

| Quarter      | Revenue ($B) | EPS ($) | Gross Margin (%) | Operating Margin (%) |
|--------------|--------------|---------|------------------|----------------------|
| Q3 FY2024    | 2.04         | 1.08    | 36.2             | 10.5                 |
| Q4 FY2024    | 2.09         | 1.11    | 36.7             | 10.9                 |
| Q1 FY2025    | 2.07         | 1.13    | 37.1             | 11.2                 |
| Q2 FY2025E   | 2.09–2.11    | 1.12–1.16| 37.0–37.2        | 11.2–11.4            |

### KPI Movement Table

| KPI                  | Q1 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025E |
|----------------------|-----------|-----------|-----------|------------|
| Book-to-Bill Ratio   | 1.05      | 1.03      | 1.02      | 1.01–1.03  |
| Backlog ($B)         | 4.8       | 5.0       | 5.1       | 5.0–5.2    |
| FCF ($M)             | 42        | 61        | -38       | 0–20       |

### Key Management Quotes

1. **“We’re seeing early signs of normalization in demand, but remain nimble in the face of dynamic tariffs and FX volatility.”**  
   _Q1 FY2025 Earnings Call_  
   _Interpretation: Management is balancing optimism with caution on external risks._

2. **“Our backlog conversion remains robust, with approximately half expected to convert in FY2025.”**  
   _Q1 FY2025 Earnings Call_  
   _Interpretation: Provides confidence in near-term revenue visibility._

3. **“We expect to see the benefits of our cost actions begin to flow through in the second half.”**  
   _Q1 FY2025 Earnings Call_  
   _Interpretation: Margin improvement could accelerate if execution is strong._

4. **“Working capital outflows in Q1 were higher than anticipated, but we are taking steps to improve efficiency.”**  
   _Q1 FY2025 Earnings Call_  
   _Interpretation: FCF risk remains, but management is focused on mitigation._

5. **“We are reaffirming our full-year guidance despite ongoing macro uncertainty.”**  
   _Q1 FY2025 Earnings Call_  
   _Interpretation: Underlines confidence in operational execution._

6. **“Margin expansion in Water Infrastructure and Applied Water segments continues to be a key driver.”**  
   _Q1 FY2025 Earnings Call_  
   _Interpretation: Segment mix is supporting overall profitability._

7. **“Restructuring and simplification initiatives are underway to drive long-term efficiency.”**  
   _Q1 FY2025 10-Q Filing_  
   _Interpretation: Cost actions could provide upside to margins if successful._

---

**Prepared by Goldman Sachs Equity Research – For Institutional Use Only**

Xylem (XYL): Margin Gains Offset by Cash Flow Risks